AIM: To find new potential biomarkers and to establish patterns for early detection of colorectal cancer. METHODS: One hundred and eighty-two serum samples including 55 from colorectal cancer (CRC) patients, 35 from colorectal adenoma (CRA) patients and 92 from healthy persons (HP) were detected by surface-enhanced laser desorption/ionization mass spectrometry (SELDI-MS). The data of spectra were analyzed by bioinformatics tools like artificial neural network (ANN) and support vector machine (SVM). RESULTS: The diagnostic pattern combined with 7 potential biomarkers could differentiate CRC patients from CRA patients with a specificity of 83%, sensitivity of 89% and positive predictive value of 89%. The diagnostic pattern combined with 4 potential biomarkers could differentiate CRC patients from HP with a specificity of 92%, sensitivity of 89% and positive predictive value of 86%. CONCLUSION: The combination of SELDI with bioinformatics tools could help find new biomarkers and establish patterns with high sensitivity and specificity for the detection of CRC.
AIM: To find new potential biomarkers and to establish patterns for early detection of colorectal cancer. METHODS: One hundred and eighty-two serum samples including 55 from colorectal cancer (CRC) patients, 35 from colorectal adenoma (CRA) patients and 92 from healthy persons (HP) were detected by surface-enhanced laser desorption/ionization mass spectrometry (SELDI-MS). The data of spectra were analyzed by bioinformatics tools like artificial neural network (ANN) and support vector machine (SVM). RESULTS: The diagnostic pattern combined with 7 potential biomarkers could differentiate CRCpatients from CRA patients with a specificity of 83%, sensitivity of 89% and positive predictive value of 89%. The diagnostic pattern combined with 4 potential biomarkers could differentiate CRCpatients from HP with a specificity of 92%, sensitivity of 89% and positive predictive value of 86%. CONCLUSION: The combination of SELDI with bioinformatics tools could help find new biomarkers and establish patterns with high sensitivity and specificity for the detection of CRC.
Authors: M Mishaeli; B Klein; E Sadikov; I Bayer; R Koren; R Gal; E Rakowsky; I Levin; B Kfir; J Schachter; T Klein Journal: Anticancer Res Date: 1998 May-Jun Impact factor: 2.480
Authors: Terence C W Poon; Tai-Tung Yip; Anthony T C Chan; Christine Yip; Victor Yip; Tony S K Mok; Conrad C Y Lee; Thomas W T Leung; Stephen K W Ho; Philip J Johnson Journal: Clin Chem Date: 2003-05 Impact factor: 8.327
Authors: Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta Journal: Lancet Date: 2002-02-16 Impact factor: 79.321
Authors: Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun Journal: CA Cancer J Clin Date: 2003 Jan-Feb Impact factor: 508.702
Authors: Judith Y M N Engwegen; Helgi H Helgason; Annemieke Cats; Nathan Harris; Johannes M G Bonfrer; Jan H M Schellens; Jos H Beijnen Journal: World J Gastroenterol Date: 2006-03-14 Impact factor: 5.742
Authors: Fraser M Smith; William M Gallagher; Edward Fox; Richard B Stephens; Elton Rexhepaj; Emanuel F Petricoin; Lance Liotta; M John Kennedy; John V Reynolds Journal: Ann Surg Date: 2007-02 Impact factor: 12.969
Authors: David F Ransohoff; Christopher Martin; Wesley S Wiggins; Ben A Hitt; Temitope O Keku; Joseph A Galanko; Robert S Sandler Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-08 Impact factor: 4.254